US Stem Cell Scientist Punished for Fraud
By Michael Cook,
BioEdge
| 09. 07. 2012
Stem cell research fraud continues, though not as spectacularly as in the lab of disgraced South Korean Hwang Woo-suk. A Harvard University researcher, Shane Mayack, was recently
disciplined by the Office of Research Integrity (ORI) of the Department of Health and Human Services for using images from other publications as her own. Dr Mayack has acknowledged her responsibility for misconduct, which led to retractions of two papers in the prestigious journals Nature and Blood.
Last year Dr Mayack discussed the scandal in an essay posted on the blog
Retraction Watch. She admitted that she had made “egregious” mistakes, but she blamed a “dysfunctional” system as well:
“… the mistakes made were serious, even egregious. I take responsibility for these mistakes, and I understand that there are and should be some degree of consequence. I am a professional, well-trained individual and more should be expected of me.
“That being said, more should be expected of all of us — the system as a whole — shouldn’t it? Errors in scientific data that make their way into publications do so...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
